Neurocognitive Disorder Clinical Trials

4 recruiting

About Neurocognitive Disorder Clinical Trials

Looking for clinical trials for Neurocognitive Disorder? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Neurocognitive Disorder trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Neurocognitive Disorder clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 53 trials

Recruiting
Phase 2

Fisetin in Mild Alzheimer's Disease

Alzheimer DiseaseAlzheimer DementiaAlzheimer Dementia (AD)+4 more
Sunnybrook Health Sciences Centre5 enrolled1 locationNCT07279714
Recruiting
Not Applicable

rTMS for Apathy Clinical Trial

DementiaAlzheimer DiseaseMild Cognitive Impairment+3 more
Sunnybrook Health Sciences Centre10 enrolled1 locationNCT05561205
Recruiting
Not Applicable

Brain Stimulation and Cognitive Training for MCI

Mild Neurocognitive DisorderCognitive DysfunctionMild Cognitive Impairment (MCI)+2 more
Medical University of South Carolina50 enrolled1 locationNCT07526740
Recruiting

The Role of Neuroinflammation on Neurocognitive Outcome in Cardiac Surgery

Postoperative Neurocognitive DisorderElderly PatientsCardiac Surgery+4 more
Ziekenhuis Oost-Limburg80 enrolled1 locationNCT07200726
Recruiting
Not Applicable

Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging

Cognitive ChangeAgingNeurocognitive Disorders, Mild
University of Florida68 enrolled1 locationNCT05457725
Recruiting
Phase 2

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

Mild Neurocognitive DisorderMajor Depressive DisorderHIV
National Institute of Allergy and Infectious Diseases (NIAID)186 enrolled40 locationsNCT06705478
Recruiting
Phase 3

A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)

DementiaBrain DiseasesCentral Nervous System Diseases+6 more
Eli Lilly and Company1,500 enrolled141 locationsNCT05508789
Recruiting
Not Applicable

Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders

Patient SatisfactionAlzheimer DiseaseCaregiver Burden+7 more
University of Michigan1,900 enrolled7 locationsNCT05929703
Recruiting

CONCEPTT Kids International Neurodevelopmental Outcomes Among Offspring of Women With Type 1 Diabetes

Neurocognitive Disorders
University of Manitoba225 enrolled10 locationsNCT05754567
Recruiting

Early Detection of Alzheimer's Disease and Affective Disorders by Automated Voice and Speech Analysis (PLATA)

Neurocognitive Disorders
Centre Hospitalier Universitaire de Nice100 enrolled1 locationNCT05943834
Recruiting
Not Applicable

Adapted Physical Activity Education in Patients With Neurocognitive Disorder

Neurocognitive Disorders
Centre Hospitalier Universitaire de Nice34 enrolled1 locationNCT05866822
Recruiting

Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

Cognitive Impairment, MildApathy in DementiaApathy+2 more
KompanionCare SAS80 enrolled5 locationsNCT07237009
Recruiting
Not Applicable

Digital Sleep Optimization for Brain Health Outcomes in Older Surgical Patients

Postoperative Neurocognitive DisorderInsomniaPostoperative Delirium+1 more
Massachusetts General Hospital50 enrolled1 locationNCT06375265
Recruiting

Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic

Neurocognitive Disorders
Baptist Health South Florida200 enrolled1 locationNCT05504681
Recruiting

The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)

Cognitive DysfunctionLiver CirrhosisNeurocognitive Disorders+1 more
University of Malaya230 enrolled1 locationNCT07418008
Recruiting
Not Applicable

Creation of an Ecological Tool Assessing Episodic Memory in Geriatrics

Memory DisordersNeurocognitive Disorders
Centre Hospitalier de Lens60 enrolled1 locationNCT05668598
Recruiting
Not Applicable

Impact of Lifestyle Interventions on Cognitive Decline in Non-alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver DiseaseNeurocognitive Disorders
Khyber Medical University Peshawar45 enrolled2 locationsNCT07294963
Recruiting
Phase 2

Efficacy and Safety of Oral Midazolam Used for the Delivery of Care in Elderly Patient With Neurocognitive Disorders and Refusing Care.

Neurocognitive Disorders
University Hospital, Grenoble30 enrolled1 locationNCT06638710
Recruiting
Phase 4

Cognitive Outcomes After Dexmedetomidine Sedation in Cardiac Surgery Patients

ConfusionCognitive DysfunctionMolecular Mechanisms of Pharmacological Action+14 more
Sunnybrook Health Sciences Centre2,400 enrolled8 locationsNCT04289142
Recruiting
Not Applicable

Nutrition-based Interventions to Prevent Cognitive Decline

Cognitive ImpairmentCognitive DysfunctionMemory Disorders+2 more
Instituto de Saude Publica da Universidade do Porto120 enrolled2 locationsNCT06853405